This bill strengthens the safety of infant formula by requiring manufacturers to test products for harmful microorganisms and report any contamination immediately to the Food and Drug Administration. When manufacturers discover contamination, they must notify the FDA within 24 hours and work with the agency to isolate, stop distributing, and dispose of affected products within specified timeframes. The FDA must then respond to manufacturers within 72 hours to discuss investigation and corrective actions, and confirm within 90 days that appropriate steps have been taken. Additionally, the bill requires the FDA to submit progress reports on implementing infant formula safety recommendations, issue quarterly supply chain reports to Congress for five years tracking product availability, and publish annual reports on best practices for maximizing both formula supply and safety. The legislation aims to prevent contamination events like the 2022 infant formula shortage crisis by improving testing protocols, faster reporting requirements, and better monitoring of the nation's formula supply chain.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.